Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹40 Cr₹31 Cr₹61 Cr₹52 Cr₹14 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹40 Cr based on Mar2024 Standalone results.
Year Revenue
Mar2024₹40 Cr
Mar2023₹31 Cr
Mar2022₹61 Cr
Mar2021₹52 Cr
Mar2020₹14 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2024 ₹40 Cr
27.93
Mar2023 ₹31 Cr
-48.80
Mar2022 ₹61 Cr
16.33
Mar2021 ₹52 Cr
279.32
Mar2020 ₹14 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹217.2 Cr -15.8% -17.6% -23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,893.0 Cr 1% 4.8% -13.5% Stock Analytics
DIVIS LABORATORIES ₹171,976.0 Cr 11.2% 7.4% 10.5% Stock Analytics
CIPLA ₹126,137.0 Cr 3.2% -0.1% -7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,712.0 Cr 0.3% -1.6% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,562.0 Cr 1.3% -3% -6.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-15.8%

-17.6%

-23.5%

SENSEX

1.6%

1.7%

1.8%


You may also like the below Video Courses